Logo Light ModeLogo Dark Mode
Why Subscribe?About UsAccreditationLearning Hub CentralLive EventsBlog

Learning Hub Central

Loading…

Contact Us

info@meccinc.com
(305) 663-1628
MEC LogoMEC MedPro LogoMEC Series LogoGlobal Meetings Logo

© 2026 MyMedFlix, All Rights Reserved.

Powered By CMEGenius™
Privacy PolicyTerms and ConditionsCancellation and Refund PolicyAI Disclosure

Learning Hub Central

Filter by title, faculty, or specialty to find the course you're looking for.

SpecialtyImmunotherapy(124 courses)
All specialties

Immunotherapy

124 courses

2026 MCM | Dealing with Long Term Effects of Breast Cancer Immunotherapy and Targeted Therapy

2026 MCM | Dealing with Long Term Effects of Breast Cancer Immunotherapy and Targeted Therapy

0.00 Credits
1 Chapter
Immunotherapy
Free
2026 MCM | Integrative Medicine and Cancer: How to Improve the Quality of Life and Well Being of Our Patients and Survivors

2026 MCM | Integrative Medicine and Cancer: How to Improve the Quality of Life and Well Being of Our Patients and Survivors

0.00 Credits
1 Chapter
Immunotherapy
Free
2026 MCM | Logistic Management of Bispecific Therapy: From Hem Malignancies to Small Cell Lung Cancer

2026 MCM | Logistic Management of Bispecific Therapy: From Hem Malignancies to Small Cell Lung Cancer

0.00 Credits
1 Chapter
Immunotherapy
Free
2025 SPS Seattle | A Review of Expanding PD-1 / PD-L1 Therapies

2025 SPS Seattle | A Review of Expanding PD-1 / PD-L1 Therapies

0.00 Credits
1 Chapter
Immunotherapy
Free
2025 SPS Seattle | Site-of-Care Practical and Economic Considerations for CAR-T Therapy

2025 SPS Seattle | Site-of-Care Practical and Economic Considerations for CAR-T Therapy

0.00 Credits
1 Chapter
Immunotherapy
Free
2025 CCC | Immune Related Adverse Events

2025 CCC | Immune Related Adverse Events

0.00 Credits
1 Chapter
Immunotherapy
Free
2025 CCC | Immunotherapy Biomarkers: What’s Next

2025 CCC | Immunotherapy Biomarkers: What’s Next

0.00 Credits
1 Chapter
Immunotherapy
Free
2025 NOSCM | Immunotherapy in First Line Metastatic Setting

2025 NOSCM | Immunotherapy in First Line Metastatic Setting

0.00 Credits
1 Chapter
Immunotherapy
Free
2025 NOSCM | Melanoma: Novel Advances in Immunotherapy

2025 NOSCM | Melanoma: Novel Advances in Immunotherapy

0.00 Credits
1 Chapter
Immunotherapy
Free
2025 NOSCM | Innovations in Thoracic Oncology in 20 Years

2025 NOSCM | Innovations in Thoracic Oncology in 20 Years

0.00 Credits
1 Chapter
Immunotherapy
Free
2025 NOSCM | Immunotherapy in Head and Neck Cancers

2025 NOSCM | Immunotherapy in Head and Neck Cancers

0.00 Credits
1 Chapter
Immunotherapy
Free
2024 MLS Cleveland | Immunotherapy Updates in Melanoma

2024 MLS Cleveland | Immunotherapy Updates in Melanoma

0.00 Credits
1 Chapter
Immunotherapy
Free
2024 NOSCM | Upfront Treatment for Common Ovarian Cancer (High Grade Serous) Versus Rare Histologies-- Focus on PARPi and Other Targeted Therapies

2024 NOSCM | Upfront Treatment for Common Ovarian Cancer (High Grade Serous) Versus Rare Histologies-- Focus on PARPi and Other Targeted Therapies

0.00 Credits
1 Chapter
Immunotherapy
Free
2024 MLS Cleveland | Immunotherapy Updates in Breast Cancer

2024 MLS Cleveland | Immunotherapy Updates in Breast Cancer

0.00 Credits
1 Chapter
Immunotherapy
Free
2024 MCM | What To Do When Patients Getting Immunotherapy Do Not Respond to Steroids (Hepatitis, Colitis, Pneumonitis, and Others)

2024 MCM | What To Do When Patients Getting Immunotherapy Do Not Respond to Steroids (Hepatitis, Colitis, Pneumonitis, and Others)

0.00 Credits
1 Chapter
Immunotherapy
Free
2024 MCM | New Platforms and Developments of Immunotherapy Biomarkers Beyond PD-L1 in Tissue?

2024 MCM | New Platforms and Developments of Immunotherapy Biomarkers Beyond PD-L1 in Tissue?

0.00 Credits
1 Chapter
Immunotherapy
Free
Perioperative Chemo/Immunotherapy and Surgical Outcomes

Perioperative Chemo/Immunotherapy and Surgical Outcomes

0.00 Credits
1 Chapter
Immunotherapy
Free
Combining Immunotherapy with Radiation for LA-NSCLC

Combining Immunotherapy with Radiation for LA-NSCLC

0.00 Credits
1 Chapter
Immunotherapy
Free
Novel Immunotherapy Approach and Targeted Therapy in Melanoma

Novel Immunotherapy Approach and Targeted Therapy in Melanoma

0.00 Credits
1 Chapter
Immunotherapy
Free
2024 NOSCM | Squamous Cell Carcinoma of Head and Neck: Where Are We in 2024?

2024 NOSCM | Squamous Cell Carcinoma of Head and Neck: Where Are We in 2024?

0.00 Credits
1 Chapter
Immunotherapy
Free
Immunotherapy and Targeted Agents in Head/Neck Cancer

Immunotherapy and Targeted Agents in Head/Neck Cancer

0.00 Credits
1 Chapter
Immunotherapy
Free
Perioperative Immunotherapy in Non-Small Cell Lung Cancer

Perioperative Immunotherapy in Non-Small Cell Lung Cancer

0.00 Credits
1 Chapter
Immunotherapy
Free
Current and Future Directions of Immunotherapy for Breast Cancer

Current and Future Directions of Immunotherapy for Breast Cancer

0.00 Credits
1 Chapter
Immunotherapy
Free
Immunotherapy For Triple Negative Breast Cancer Optimal Chemotherapy Partners, New Directors, And Managing Toxicity

Immunotherapy For Triple Negative Breast Cancer Optimal Chemotherapy Partners, New Directors, And Managing Toxicity

0.00 Credits
1 Chapter
Immunotherapy
Free
Establishing Immunotherapy Management in Gastrointestinal Cancers

Establishing Immunotherapy Management in Gastrointestinal Cancers

0.00 Credits
1 Chapter
Immunotherapy
Free
Showing 25 of 124 courses

Contact Us

info@meccinc.com
(305) 663-1628
MEC LogoMEC MedPro LogoMEC Series LogoGlobal Meetings Logo

© 2026 MyMedFlix, All Rights Reserved.

Powered By CMEGenius™
Privacy PolicyTerms and ConditionsCancellation and Refund PolicyAI Disclosure